Across CCLE and GDSC cell-line panels, response to Vismodegib is significantly associated with the pathway activity of multiple pathways, with OVARY cell lines showing a particularly strong set of associations.
The most reproducible Vismodegib response-associated pathways across cancer lineages are Regulation of actin filament bundle assembly, 'de novo' UMP biosynthetic process, and Positive regulation of canonical NF-kappaB signal transduction, each associated with drug response in up to 10 lineages. Since the analysis identifies associations rather than directional relationships, both response-to-biomarker and biomarker-to-response views are provided.
Each biomarker is linked to its corresponding Q-omics profile. The scatter plot shows the strongest observed association, Vismodegib response versus Regulation of actin filament bundle assembly pathway activity in OVARY (Pearson r = -0.40).